Status:

UNKNOWN

Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes

Lead Sponsor:

Universidad de Guanajuato

Collaborating Sponsors:

Hospital Regional de Alta Especialidad del Bajio

Conditions:

Prediabetic State

Insulin Resistance

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

Type 2 diabetes is a chronic disease that has reached global epidemic proportions due to the growing number of patients in all countries; It has become the disease that causes more chronic and acute c...

Detailed Description

The main goal of this clinical trial is to compare the effect of two different treatments during 12 months: 1. Lifestyle modification program + metformin 1700mg every 24 hours. 2. Lifestyle modificat...

Eligibility Criteria

Inclusion

  • Patients with prediabetes, defined for the existence of one or both of the following conditions: 1) impaired fasting glucose (Fasting glucose between 100 and 125 mg/dL), 2) impaired glucose tolerance (Glucose between 140 and 199 mg/dL at the 2 hours of the Oral Glucose Tolerance test (OGTT)
  • Patients who accept to participate in the study and sign the informed consent letter.

Exclusion

  • Patients with diagnosed Type 2 Diabetes Mellitus previously or detected during the OGTT
  • Patients in actual treatment or during the last 3 months with metformin, pioglitazone or another antidiabetic drug, including insulin.
  • Serum creatinine \> 1.6 mg/dL
  • Hypertriglyceridemia very high (\>500 mg/dL)
  • Pregnant women
  • Altered arterial hypertension (Systolic \> 180 mmHg or Diastolic \>105 mmHg)
  • Excessive alcohol intake, acute or chronic
  • Medications or medical conditions that affect glucose homeostasis (thiazides, beta blockers, glucocorticoids for systemic use, weight-reducing drugs or anorexigenics, Cushing's syndrome, Thyrotoxicosis.

Key Trial Info

Start Date :

September 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2020

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT04134650

Start Date

September 1 2019

End Date

July 1 2020

Last Update

October 25 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidad de Guanajuato

León, Guanauato, Mexico, 37670